Skip to main content

Infectious Disease

Test
Study Confirms No Benefit to Taking Ivermectin for COVID-19 Symptoms
|
  • Research
  • COVID
  • Infectious Disease
Test
Study Evaluates Biomarker to Help Curb Unnecessary Antibiotic Use
|
  • Research
  • Infectious Disease
Test
New Pan-Coronavirus Vaccine Passes Key Experiments, Demonstrates Protection
|
  • Research
  • COVID
  • Infectious Disease
Test
Study Finds No Benefit to Taking Fluvoxamine for COVID-19 Symptoms
|
  • Research
  • Infectious Disease
Test
Federal Grant to Duke University School of Medicine Expands HIV Research
|
  • Grants/Awards
  • HIV
  • Infectious Disease
Test
DCRI selected as Clinical Trials Data Coordinating Center for NIH RECOVER Long COVID Initiative
|
  • Research
  • COVID
  • Infectious Disease
Test
CRISPR Technology Demonstrates Success in Preventing and Treating COVID
|
  • Research
  • COVID
  • Infectious Disease
Test
Study Finds No Benefit to Taking Fluticasone Furoate for COVID-19 Symptoms
|
  • Research
  • COVID
  • Infectious Disease
Test
Monoclonal Antibody Treatment Reduced Deaths in Hospitalized COVID Patients
|
  • Research
  • COVID
  • Infectious Disease
Test
Newly Identified Aspect of Cell Death May Impact the Future of Fighting Diseases
|
  • Research
  • Infectious Disease
Test
Investigational Mucosal COVID Vaccine Protects Against Disease and Transmission
|
  • Research
  • COVID
  • Infectious Disease
Test
Indications of Moral Injury Similar between Combat Veterans and COVID-19 Health Care Workers
|
  • Research
  • Infectious Disease
  • Psychiatry
  • COVID
Test
Study Shows mRNA Vaccine Technology Can Be Used For HIV Vaccines
|
  • Research
  • HIV
  • Infectious Disease
Test
Universal Masking in Schools is Shown to Reduce Spread of COVID-19
|
  • Research
  • Children's Health
  • Infectious Disease
  • COVID
Test
Study Will Test Higher Dose of Ivermectin to Treat Mild-to-Moderate COVID-19
|
  • Research
  • Infectious Disease
  • COVID
Test
Omicron Antibodies Persist 6 Months after Moderna Vaccine Boost But Are 6 Times Lower
|
  • Clinical Care
  • Health System
  • Research
  • Infectious Disease
  • COVID
Test
Hospital Room Surfaces Pose Low Risk of Spreading SARS-CoV-2
|
  • Research
  • Infectious Disease
  • COVID
Test
With ‘Test-to-Stay,’ Children and Staff Can Safely Remain in School After COVID Exposures
|
  • Research
  • Children's Health
  • Infectious Disease
  • COVID
Test
Duke Institute Lands Federal Contract to Make Vaccine Candidates
|
  • Grants/Awards
  • Research
  • HIV
  • Infectious Disease
Test
Duke Physicians Discuss Details of Omicron Variant
|
  • Clinical Care
  • Health System
  • Research
  • Infectious Disease
  • COVID
Test
A Third of Caregivers of Kids with Cancer Have Hesitancy on COVID Vaccine
|
  • Research
  • Children's Health
  • Cancer
  • Infectious Disease
Test
Duke, UNC-Chapel Hill Scientists Identify New Antibody For COVID-19 and Variants
|
  • Research
  • Infectious Disease
  • COVID
Test
Duke Researchers Receive Grant to Roll Out Next-Generation Coronavirus Vaccine
|
  • Grants/Awards
  • COVID
  • Infectious Disease
Test
Data Finds Universal Masking Limits School Transmission of COVID-19 Despite Delta Variant
|
  • Research
  • Children's Health
  • Infectious Disease
Test
Harnett County Man Home After Lengthy COVID-19 Battle
|
  • Clinical Care
  • Health System
  • Infectious Disease
Subscribe to Infectious Disease